Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Oramed Pharmaceuticals Inc. (ORMP)

8.915   -1.005 (-10.13%) 01-21 19:09
Open: 9.61 Pre. Close: 9.92
High: 9.82 Low: 8.76
Volume: 1,673,390 Market Cap: 341M
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.832 - 9.893 9.893 - 9.937
Low: 8.627 - 8.697 8.697 - 8.746
Close: 8.817 - 8.921 8.921 - 8.994

Technical analysis

as of: 2022-01-21 4:29:07 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 15.44     One year: 18.66
Support: Support1: 8.76    Support2: 7.29
Resistance: Resistance1: 13.22    Resistance2: 15.98
Pivot: 11.68
Moving Average: MA(5): 10.16     MA(20): 12.26
MA(100): 19.47     MA(250): 14.98
MACD: MACD(12,26): -1.80     Signal(9): -1.73
Stochastic oscillator: %K(14,3): 3.49     %D(3): 3.55
RSI: RSI(14): 23.63
52-week: High: 31.54  Low: 6.80  Change(%): 28.5
Average Vol(K): 3-Month: 977  10-Days: 796

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ORMP has closed above bottom band by 0.1%. Bollinger Bands are 15.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 12 Jan 2022
Oramed Issues Annual Message to Shareholders USA - English - USA - PRNewswire

Thu, 06 Jan 2022
Oramed Pharmaceuticals Updates 1 Key Risk Factor - Nasdaq

Wed, 29 Dec 2021
Oramed Subsidiary Oravax Medical Signs Cooperation and Purchase Agreement for an Initial Pre-Purchase of 10 Million Doses of Oral COVID-19 Vaccines with Tan Thanh Holdings to Commercialize in Southeast Asia - PRNewswire

Thu, 23 Dec 2021
Oramed Pharmaceuticals, Inc. (ORMP) Stock Climbs 3.88% This Week; Should You Buy? - InvestorsObserver

Wed, 08 Dec 2021
Oramed Pharmaceuticals Appoints Chief Legal Officer USA - English - PRNewswire

Wed, 24 Nov 2021
Should You Sell Oramed Pharmaceuticals, Inc. (ORMP) Stock Wednesday Morning? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Outperform Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 38
Shares Float (M) 37
% Held by Insiders 7.84
% Held by Institutions 17.81
Shares Short (K) 2,210
Shares Short P. Month (K) 902

Stock Financials

EPS -0.770
EPS Est This Year -0.780
EPS Est Next Year -1.250
Book Value (p.s.) 4.470
Profit Margin
Operating Margin -978.76
Return on Assets (ttm) -14.8
Return on Equity (ttm) -25.7
Qtrly Rev. Growth
Gross Profit (p.s.) 0.071
Sales Per Share 0.071
EBITDA (p.s.) -0.689
Qtrly Earnings Growth
Operating Cash Flow (M) -22
Levered Free Cash Flow (M) -11

Stock Valuations

PE Ratio -11.58
PEG Ratio
Price to Book value 1.99
Price to Sales 126.39
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.